Traditional X-rays, move over—there may be a new gold standard for joint imaging to assess even the smallest changes that can signal the onset of arthritis, as reported recently in the journal Scientific Reports.1 Utilizing the combined expertise of radiologists, rheumatologists and engineers, University of Cambridge researchers developed an algorithm to monitor the joints of…
Donah Zack Crawford in the Spotlight: Why the ARHP Is for Me
Donah Zack Crawford, MA, was a research coordinator at the University of Pennsylvania, focused on premenstrual syndrome and perimenopause, when her symptoms first started. “Someone suggested I see a rheumatologist,” she says, and not long after, Philadelphia-based physician Bruce Hoffman, MD, diagnosed her with rheumatoid arthritis. It was the mid-1990s, and treatment options were limited….
RA & Huntington’s Disease: New Epigenetic Technology Uncovers Overlap
Researchers working to decode the epigenetic landscape for rheumatoid arthritis (RA) were surprised to discover a connection to Huntington’s disease, a finding that could pave the way to discoveries of new therapeutic targets. By developing new methods to integrate data from epigenetic technologies, scientists at the University of California, San Diego (UCSD), set out to…
A Rheumatology Fellow Shares Her Journey to Capitol Hill via the ACR’s Advocacy 101 Program
In summer 2017, I was a few months post-partum when I received an email announcing applications for the ACR’s Advocacy 101 program. It would take only a few days, but I asked my division director if it would be worth the time commitment. He questioned the career benefits of advocacy, but encouraged me to apply…
Biomarkers for Knee OA
Knee osteoarthritis (OA) accounts for more than 80% of OA disease burden and has doubled in prevalence in the mid-20th century in the U.S. when compared with people who lived during early industrial era (1800s to early 1900s).1 Currently, the diagnostic and treatment armamentaria are limited. Disease progression is measured by joint space narrowing on…
The Value of Repeat Antibody Testing in Lupus Patients
A recent study suggests costly antibody screening among patients with systemic lupus erythematosus could be reduced by limiting repeat screening of extractable nuclear antigens (ENAs). Researchers investigated how often results changed for anti-ENA and other commonly screened antibodies in repeat testing of patients with SLE. The findings were published in the Journal of Rheumatology.1 “We theorized,…
Lupus Nephritis Improvements: A 5-Decade Retrospective Review
The incidence of lupus nephritis in patients with systemic lupus erythematosus (SLE) has decreased over the past 50 years, according to a study from Gabriella Moroni, who works in the Nephrology Unit at Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico in Milano, Italy.1 Typically, renal involvement is part of the disease course for two-thirds of…
Impact of Medicare Billing Changes Varies by Specialty
NEW YORK (Reuters Health)—The proposed collapsing of payment amounts for levels 2 to 5 evaluation and management (E/M) services by the U.S. Centers for Medicare and Medicaid Services (CMS) would have different financial impacts on different specialties, researchers report. “Specialists that tend to have more complicated and/or longer visits would lose money, and specialists that…
Walmart, Home Depot Adopt Health Insurer Tactic in Drug Copay Battle
NEW YORK (Reuters)—Walmart and Home Depot, two of the top 10 U.S. employers, have embraced a health insurance strategy that punishes drugmakers for using discount cards to keep patients from switching or stopping their medications. Large U.S. companies have started tightly managing how employees and their family members use these popular discount, or copay, cards…
New RheumPAC Chair Zachary Wallace, MD, MSc, Promotes a Louder Voice for Rheumatology
A patient Zachary Wallace, MD, MSc, met during his third year of medical school at Georgetown University helped lead him to his passion for rheumatology. He was completing a clinical rotation in medicine, and the experience made rheumatologic disease tangible for him. “She had lupus, and I became interested in her case,” he says. Later,…
- « Previous Page
- 1
- …
- 262
- 263
- 264
- 265
- 266
- …
- 777
- Next Page »